LEITAT accepted as core member of EIT Health


On January 2018, LEITAT will be a core member of EIT Health! This upgrades its current membership and positioning together with other core members such as the University of Barcelona, Karolinska Institute, Roche, and ATOS amongst others.

This is happening at a moment where EIT Health funding is expected to increase to 80-100 m € per year by 2022 to create impact, as stated Sylvie Bove, CEO of EIT Health in an interview with Biocat.